Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mining biomarkers in human sera using proteomic tools.

Rulin Zhang1, Lisa Barker, Deborah Pinchev

  • 1Syn-X Pharma, Toronto, Ontario, Canada. rzhang@synxpharma.com

Proteomics
|January 20, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perspective of the European Cystic Fibrosis Society on Improving Global Cystic Fibrosis Care.

Pediatric pulmonology·2026
Same author

Cystic fibrosis nutrition: Addressing emerging trends following the 2024 ESPEN-ESPGHAN-ECFS guidelines. Expert opinion recommendations.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2026
Same author

Partnership between cystic fibrosis centres in Europe: The Twinning Project.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2026
Same author

Giardiasis in Japan, the United States of America, and Europe from 2007 to 2023, highlighting a decline during the COVID-19 pandemic.

PLoS neglected tropical diseases·2026
Same author

Prevalence and correlates of active syphilis diagnosed using serological assays and the molecular research-use-only Aptima <i>Treponema pallidum</i> assay among pregnant women in Zambia, 2023.

Frontiers in public health·2026
Same author

Development and internal validation of a complexity scoring system for elbow arthroplasty: The Elbow Arthroplasty Severity (EASe) score.

Shoulder & elbow·2026
Same journal

Identification of Novel Interacting Proteins of FUZ and GPR161.

Proteomics·2026
Same journal

Light-Induced Proteomic Changes in Pseudomonas aeruginosa Biofilms.

Proteomics·2026
Same journal

Decade-Resolved Proteomic Profiling of Gastric Cancer FFPE Archives: Evaluating Storage-Associated Shifts and Signal Stability Over 50 Years.

Proteomics·2026
Same journal

Proteome-Scale Mining of Metal-Associated Proteins of Monkeypox Virus.

Proteomics·2026
Same journal

Optimized Sample Handling Minimizes Peptide Adsorption to Plastics to Enable High Sensitivity Evosep Based Chemical Proteomics.

Proteomics·2026
Same journal

Toward Predicting Pandemic Potential: A Comparative Analysis of Virus-Host Interactions Between Diverse Influenza A Viruses and the Human Innate Immune System.

Proteomics·2026
See all related articles

Researchers identified novel protein biomarkers in blood for Alzheimer's disease, insulin resistance/type-2 diabetes, and congestive heart failure. These findings may aid in developing new diagnostic tools for these conditions.

Area of Science:

  • Proteomics
  • Biomarker Discovery
  • Clinical Chemistry

Background:

  • Serum protein analysis is challenging due to high-abundance proteins like albumin masking low-abundance disease biomarkers.
  • Traditional methods like 2D electrophoresis struggle to detect low-abundance proteins in complex serum samples.

Purpose of the Study:

  • To identify novel protein biomarkers in serum for Alzheimer's disease (AD), insulin resistance/type-2 diabetes (IR/D2), and congestive heart failure (CHF).
  • To explore the potential of these identified biomarkers for diagnostic applications.

Main Methods:

  • Utilized a multi-omics approach combining multidimensional liquid chromatography and gel electrophoresis.
  • Employed mass spectrometry techniques, including MALDI-Q-TOF and IT LC-MS/MS, for protein identification.

Related Experiment Videos

  • Validated biomarker candidates using Western blot and enzyme-linked immunosorbent assay (ELISA).

    • Main Results:

    • Identified 36 proteins with higher levels in disease sera and 8 proteins with higher levels in control sera.
    • Found elevated levels of haptoglobin and hemoglobin in sera of AD, IR/D2, and CHF patients.
    • Observed differential expression of complement pathway proteins, fibrinogen fragments, and other proteins in IR/D2 and AD patients compared to controls.

    Conclusions:

    • The study successfully identified potential protein biomarkers for AD, IR/D2, and CHF.
    • These identified protein changes show promise for developing novel diagnostic tools and therapeutic strategies.